Christoffer Tell - Newbury Pharmaceuticals Chief Officer

NEWBRY Stock   3.44  0.08  2.38%   

Insider

Christoffer Tell is Chief Officer of Newbury Pharmaceuticals AB
Age 36
Phone46 46 12 11 20
Webhttps://www.newburypharma.com

Similar Executives

Found 2 records

INSIDER Age

Christine RyanGabather AB
N/A
MichaelRobin WittGabather AB
N/A
Newbury Pharmaceuticals AB (NEWBRY) is traded on Stockholm Exchange in Sweden and employs 6 people.

Management Performance

Newbury Pharmaceuticals Leadership Team

Elected by the shareholders, the Newbury Pharmaceuticals' board of directors comprises two types of representatives: Newbury Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Newbury. The board's role is to monitor Newbury Pharmaceuticals' management team and ensure that shareholders' interests are well served. Newbury Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Newbury Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Andrea Karnitschky, Sr Devel
Fredrik Hellqvist, VP Marketing
Karl Karlsson, Founder Chairman
Lars Minor, Chief Officer
Christoffer Tell, Chief Officer

Newbury Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Newbury Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Newbury Stock

Newbury Pharmaceuticals financial ratios help investors to determine whether Newbury Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Newbury with respect to the benefits of owning Newbury Pharmaceuticals security.